Breaking News Instant updates and real-time market news.

OKTA

Okta

$246.74 /

+2.4 (+0.98%)

07:11
05/27/21
05/27
07:11
05/27/21
07:11

Okta 'nicely exceeded' billings growth forecast, says Mizuho

Okta last night reported a good fiscal Q1, led by normalized billings growth of 40% year-over-year that "nicely exceeded" the Street's 29% forecast, Mizuho analyst Gregg Moskowitz tells investors in a research note. The company also significantly raised its fiscal 2022 guidance, which now incorporates the recently acquired Auth0, adds the analyst. However, Moskowitz says management "surprisingly declined" to provide the expected financial contribution from Auth0 and in another surprise, CFO Mike Kourey is stepping down. He remains bullish on Okta's fundamentals, but he'd like to see "evidence of strong execution inclusive of Auth0." Moskowitz keeps a Neutral rating on the shares with a $255 price target.

  • 07

    Jun

  • 17

    Jun

OKTA Okta
$246.74 /

+2.4 (+0.98%)

05/27/21 Piper Sandler
Piper Sandler sees a 'little uncertainty' following Q1 beat by Okta
05/24/21 Stifel
Okta initiated with a Hold at Stifel
04/23/21 KeyBanc
Okta price target raised to $316 from $280 at KeyBanc
04/22/21
Fly Intel: Top five analyst initiations

TODAY'S FREE FLY STORIES

Conference/Events
Infinity Pharmaceuticals management to meet virtually with Piper Sandler » 08:20
06/15/21
06/15
08:20
06/15/21
08:20
INFI

Infinity Pharmaceuticals

$3.38 /

-0.075 (-2.17%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INFI Infinity Pharmaceuticals
$3.38 /

-0.075 (-2.17%)

INFI Infinity Pharmaceuticals
$3.38 /

-0.075 (-2.17%)

03/23/21 B. Riley Securities
Infinity Pharmaceuticals price target lowered to $7 from $8 at B. Riley
03/18/21 Truist
Infinity Pharmaceuticals initiated with a Buy at Truist
03/18/21 Truist
Infinity Pharmaceuticals initiated with a Buy at Truist
03/17/21 JonesTrading
Infinity Pharmaceuticals has 'catalyst heavy' 2021, says JonesTrading
INFI Infinity Pharmaceuticals
$3.38 /

-0.075 (-2.17%)

  • 12
    Feb
INFI Infinity Pharmaceuticals
$3.38 /

-0.075 (-2.17%)

Hot Stocks
Biocept received over 420,000 samples for SARS-CoV-2 testing since June 2020 » 08:20
06/15/21
06/15
08:20
06/15/21
08:20
BIOC

Biocept

$4.58 /

-0.07 (-1.51%)

Biocept announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BIOC Biocept
$4.58 /

-0.07 (-1.51%)

BIOC Biocept
$4.58 /

-0.07 (-1.51%)

08/13/20 Maxim
Biocept price target raised to $2 from $1 at Maxim
BIOC Biocept
$4.58 /

-0.07 (-1.51%)

BIOC Biocept
$4.58 /

-0.07 (-1.51%)

Hot Stocks
Wireless Telecom signs over $2M in contracts with 4 new customers » 08:19
06/15/21
06/15
08:19
06/15/21
08:19
WTT

Wireless Telecom

$2.05 /

+0.11 (+5.67%)

Wireless Telecom…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WTT Wireless Telecom
$2.05 /

+0.11 (+5.67%)

WTT Wireless Telecom
$2.05 /

+0.11 (+5.67%)

05/14/21 B. Riley
Wireless Telecom price target raised to $2.75 from $2.50 at B. Riley
05/03/21 B. Riley
Wireless Telecom transferred with Buy rating at B. Riley
10/01/20 B. Riley Securities
B. Riley starts 'undervalued' Wireless Telecom with Buy, $2.50 target
10/01/20 B. Riley Securities
Wireless Telecom initiated with a Buy at B. Riley Securities
Hot Stocks
Alignment Healthcare to expand further in North Carolina in 2022 » 08:18
06/15/21
06/15
08:18
06/15/21
08:18
ALHC

Alignment Healthcare

$24.57 /

+1.19 (+5.09%)

Alignment Healthcare…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALHC Alignment Healthcare
$24.57 /

+1.19 (+5.09%)

ALHC Alignment Healthcare
$24.57 /

+1.19 (+5.09%)

06/10/21 BofA
Clover Health downgraded to Underperform from Neutral at BofA
04/20/21 Raymond James
Alignment Healthcare initiated with an Outperform at Raymond James
04/20/21 Morgan Stanley
Alignment Healthcare initiated with an Overweight at Morgan Stanley
04/20/21 BofA
Alignment Healthcare initiated with a Neutral at BofA
  • 26
    Mar
ALHC Alignment Healthcare
$24.57 /

+1.19 (+5.09%)

ALHC Alignment Healthcare
$24.57 /

+1.19 (+5.09%)

Conference/Events
Ellington Financial management to meet virtually with Piper Sandler » 08:17
06/15/21
06/15
08:17
06/15/21
08:17
EFC

Ellington Financial

$19.39 /

+0.16 (+0.83%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EFC Ellington Financial
$19.39 /

+0.16 (+0.83%)

EFC Ellington Financial
$19.39 /

+0.16 (+0.83%)

06/07/21 UBS
Ellington Financial downgraded to Neutral from Buy at UBS
05/19/21 BTIG
Ellington Financial price target raised to $19 from $18.50 at BTIG
01/15/21 UBS
Ellington Financial initiated with a Buy at UBS
12/18/20 Keefe Bruyette
Ellington Financial upgraded to Outperform from Market Perform at Keefe Bruyette
EFC Ellington Financial
$19.39 /

+0.16 (+0.83%)

Hot Stocks
Codiak BioSciences expands executive leadership » 08:16
06/15/21
06/15
08:16
06/15/21
08:16
CDAK

Codiak

$25.48 /

-1.18 (-4.43%)

Codiak BioSciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CDAK Codiak
$25.48 /

-1.18 (-4.43%)

CDAK Codiak
$25.48 /

-1.18 (-4.43%)

12/31/20 Wedbush
Codiak price target raised to $31 from $19 at Wedbush
11/09/20
Fly Intel: Top five analyst initiations
11/09/20 Wedbush
Codiak initiated with an Outperform at Wedbush
11/08/20 Goldman Sachs
Codiak initiated with a Buy at Goldman Sachs
CDAK Codiak
$25.48 /

-1.18 (-4.43%)

  • 12
    Feb
  • 14
    Oct
CDAK Codiak
$25.48 /

-1.18 (-4.43%)

Hot Stocks
EDAP TMS announces appointment of Ryan Rhodes as CEO of company's subsidiary » 08:15
06/15/21
06/15
08:15
06/15/21
08:15
EDAP

EDAP TMS

$6.78 /

+0.05 (+0.74%)

EDAP TMS announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EDAP EDAP TMS
$6.78 /

+0.05 (+0.74%)

EDAP EDAP TMS
$6.78 /

+0.05 (+0.74%)

04/28/21
Fly Intel: Top five analyst initiations
04/28/21 Piper Sandler
EDAP TMS initiated with an Overweight at Piper Sandler
04/01/21 H.C. Wainwright
EDAP TMS price target raised to $12 from $10 at H.C. Wainwright
01/25/21 Lake Street
EDAP TMS initiated with a Buy at Lake Street
EDAP EDAP TMS
$6.78 /

+0.05 (+0.74%)

  • 23
    Apr
EDAP EDAP TMS
$6.78 /

+0.05 (+0.74%)

Conference/Events
Akoya Biosciences management to meet virtually with Piper Sandler » 08:14
06/15/21
06/15
08:14
06/15/21
08:14
AKYA

Akoya Biosciences

$19.61 /

-0.39 (-1.95%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AKYA Akoya Biosciences
$19.61 /

-0.39 (-1.95%)

AKYA Akoya Biosciences
$19.61 /

-0.39 (-1.95%)

05/11/21 JPMorgan
Akoya Biosciences initiated with an Overweight at JPMorgan
05/11/21 Morgan Stanley
Morgan Stanley starts Akoya Biosciences at Overweight with $26 price target
05/11/21 Morgan Stanley
Akoya Biosciences initiated with an Overweight at Morgan Stanley
05/11/21 Piper Sandler
Akoya Biosciences initiated with an Overweight at Piper Sandler
AKYA Akoya Biosciences
$19.61 /

-0.39 (-1.95%)

  • 16
    Apr
AKYA Akoya Biosciences
$19.61 /

-0.39 (-1.95%)

Conference/Events
Akoya Biosciences management to meet virtually with Piper Sandler » 08:14
06/15/21
06/15
08:14
06/15/21
08:14
AKYA

Akoya Biosciences

$19.61 /

-0.39 (-1.95%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AKYA Akoya Biosciences
$19.61 /

-0.39 (-1.95%)

AKYA Akoya Biosciences
$19.61 /

-0.39 (-1.95%)

05/11/21 JPMorgan
Akoya Biosciences initiated with an Overweight at JPMorgan
05/11/21 Morgan Stanley
Morgan Stanley starts Akoya Biosciences at Overweight with $26 price target
05/11/21 Morgan Stanley
Akoya Biosciences initiated with an Overweight at Morgan Stanley
05/11/21 Piper Sandler
Akoya Biosciences initiated with an Overweight at Piper Sandler
AKYA Akoya Biosciences
$19.61 /

-0.39 (-1.95%)

  • 16
    Apr
AKYA Akoya Biosciences
$19.61 /

-0.39 (-1.95%)

Hot Stocks
OptimizeRx discusses 2021 strategic operating plan » 08:13
06/15/21
06/15
08:13
06/15/21
08:13
OPRX

OptimizeRx

$50.14 /

-0.05 (-0.10%)

OptimizeRx discusses…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OPRX OptimizeRx
$50.14 /

-0.05 (-0.10%)

OPRX OptimizeRx
$50.14 /

-0.05 (-0.10%)

05/07/21 B. Riley
OptimizeRx price target raised to $80 from $75 at B. Riley
04/12/21 RBC Capital
OptimizeRx initiated with an Outperform at RBC Capital
02/25/21 B. Riley Securities
OptimizeRx price target raised to $75 from $60 at B. Riley Securities
02/25/21 Roth Capital
OptimizeRx price target raised to $85 from $70 at Roth Capital
OPRX OptimizeRx
$50.14 /

-0.05 (-0.10%)

  • 09
    Feb
OPRX OptimizeRx
$50.14 /

-0.05 (-0.10%)

Conference/Events
Abiomed management to meet virtually with Piper Sandler » 08:13
06/15/21
06/15
08:13
06/15/21
08:13
ABMD

Abiomed

$302.32 /

+3.13 (+1.05%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ABMD Abiomed
$302.32 /

+3.13 (+1.05%)

ABMD Abiomed
$302.32 /

+3.13 (+1.05%)

06/08/21 Piper Sandler
Tweet suggests Abiomed study trending in right direction, says Piper Sandler
05/06/21 Raymond James
Abiomed could face new competition from Boston Scientific, says Raymond James
04/29/21 Piper Sandler
Abiomed earnings selloff a buying opportunity, says Piper Sandler
03/16/21 Piper Sandler
Abbott study challenging Abiomed's Impella halted, says Piper Sandler
ABMD Abiomed
$302.32 /

+3.13 (+1.05%)

ABMD Abiomed
$302.32 /

+3.13 (+1.05%)

Hot Stocks
Apollo Medical appoints Jeremy Jackson as Chief Quality Officer » 08:10
06/15/21
06/15
08:10
06/15/21
08:10
AMEH

Apollo Medical

$48.82 /

+0.41 (+0.85%)

Apollo Medical Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMEH Apollo Medical
$48.82 /

+0.41 (+0.85%)

AMEH Apollo Medical
$48.82 /

+0.41 (+0.85%)

AMEH Apollo Medical
$48.82 /

+0.41 (+0.85%)

Hot Stocks
First American settles with SEC over disclosure controls for $487,616 » 08:10
06/15/21
06/15
08:10
06/15/21
08:10
FAF

First American

$65.59 /

-0.42 (-0.64%)

First American Financial…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FAF First American
$65.59 /

-0.42 (-0.64%)

FAF First American
$65.59 /

-0.42 (-0.64%)

05/03/21 Credit Suisse
First American initiated with an Outperform at Credit Suisse
04/15/21 Truist
First American price target raised to $72 from $66 at Truist
02/12/21 Susquehanna
First American price target raised to $67 from $63 at Susquehanna
02/12/21 Barclays
First American price target raised to $73 from $68 at Barclays
FAF First American
$65.59 /

-0.42 (-0.64%)

Hot Stocks
The Real Brokerage Inc. commences trading on Nasdaq » 08:10
06/15/21
06/15
08:10
06/15/21
08:10
REAX

The Real Brokerage Inc.

$9.21 /

+0.21 (+2.33%)

The Real Brokerage…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Eyenovia provides update on three Phase 3 programs » 08:10
06/15/21
06/15
08:10
06/15/21
08:10
EYEN

Eyenovia

$5.47 /

+0.03 (+0.55%)

Eyenovia provided a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EYEN Eyenovia
$5.47 /

+0.03 (+0.55%)

EYEN Eyenovia
$5.47 /

+0.03 (+0.55%)

04/01/21 H.C. Wainwright
Eyenovia price target raised to $8 from $6 at H.C. Wainwright
03/01/21 Northland
Eyenovia initiated with an Outperform at Northland
12/30/20 H.C. Wainwright
H.C. Wainwright reiterates $6 target on Eyenovia after new drug submission
10/23/20 H.C. Wainwright
Eyenovia price target lowered to $6 from $7 at H.C. Wainwright
EYEN Eyenovia
$5.47 /

+0.03 (+0.55%)

  • 19
    Aug
Hot Stocks
Proterra to trade under PTRA and PTRAW symbols » 08:08
06/15/21
06/15
08:08
06/15/21
08:08
PTRA

Proterra

/

+

, ACTC

ArcLight Clean Transition

$18.08 /

-0.95 (-4.99%)

Proterra (PTRA) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACTC ArcLight Clean Transition
$18.08 /

-0.95 (-4.99%)

ACTC ArcLight Clean Transition
$18.08 /

-0.95 (-4.99%)

ACTC ArcLight Clean Transition
$18.08 /

-0.95 (-4.99%)

Hot Stocks
Aramark announces exclusive partnership with Talon » 08:08
06/15/21
06/15
08:08
06/15/21
08:08
ARMK

Aramark

$37.64 /

-0.365 (-0.96%)

Aramark has secured an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ARMK Aramark
$37.64 /

-0.365 (-0.96%)

ARMK Aramark
$37.64 /

-0.365 (-0.96%)

12/08/20 Barclays
Aramark price target raised to $40 from $35 at Barclays
11/18/20 RBC Capital
Aramark price target raised to $31 from $28 at RBC Capital
11/18/20 Barclays
Aramark price target raised to $35 from $25 at Barclays
10/22/20 Citi
Citi downgrades Aramark to Neutral with normalcy still year away
ARMK Aramark
$37.64 /

-0.365 (-0.96%)

ARMK Aramark
$37.64 /

-0.365 (-0.96%)

Hot Stocks
Urban Tea announces name change to Bit Brother Limited » 08:07
06/15/21
06/15
08:07
06/15/21
08:07
BTB

Bit Brother Limited

/

+

, MYT

Urban Tea

$2.29 /

+0.14 (+6.51%)

Urban Tea (MYT), is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MYT Urban Tea
$2.29 /

+0.14 (+6.51%)

Initiation
Concentrix initiated with an Outperform at Barrington » 08:07
06/15/21
06/15
08:07
06/15/21
08:07
CNXC

Concentrix

$152.08 /

-2.09 (-1.36%)

Barrington analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CNXC Concentrix
$152.08 /

-2.09 (-1.36%)

CNXC Concentrix
$152.08 /

-2.09 (-1.36%)

01/07/21 Cross Research
Concentrix initiated with a Buy at Cross Research
12/08/20 Stifel
Synnex downgraded to Hold from Buy at Stifel
12/07/20 BofA
Concentrix initiated with a Buy at BofA
12/07/20 BofA
Concentrix initiated with a Buy at BofA
CNXC Concentrix
$152.08 /

-2.09 (-1.36%)

CNXC Concentrix
$152.08 /

-2.09 (-1.36%)

Hot Stocks
Enlivex Therapeutics issued European patent for Allocetra » 08:06
06/15/21
06/15
08:06
06/15/21
08:06
ENLV

Enlivex Therapeutics

$9.75 /

+0.12 (+1.25%)

Enlivex Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ENLV Enlivex Therapeutics
$9.75 /

+0.12 (+1.25%)

ENLV Enlivex Therapeutics
$9.75 /

+0.12 (+1.25%)

03/02/21 H.C. Wainwright
Enlivex Therapeutics price target raised to $33 from $22 at H.C. Wainwright
  • 10
    Feb
ENLV Enlivex Therapeutics
$9.75 /

+0.12 (+1.25%)

ENLV Enlivex Therapeutics
$9.75 /

+0.12 (+1.25%)

Hot Stocks
Xperi's TiVo signs master services agreement with NCTC » 08:05
06/15/21
06/15
08:05
06/15/21
08:05
XPER

Xperi

$21.79 /

-0.56 (-2.51%)

TiVo, a wholly-owned…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XPER Xperi
$21.79 /

-0.56 (-2.51%)

XPER Xperi
$21.79 /

-0.56 (-2.51%)

02/24/21 B. Riley Securities
Xperi price target raised to $34 from $33 at B. Riley Securities
11/16/20 B. Riley Securities
Xperi shares can nearly double from current levels, says B. Riley Securities
11/10/20 BWS Financial
Xperi settlement paves way for $26 share price, says BWS Financial
09/28/20 BWS Financial
Walmart availability could mean Xperi ready for mass market, says BWS Financial
XPER Xperi
$21.79 /

-0.56 (-2.51%)

XPER Xperi
$21.79 /

-0.56 (-2.51%)

Hot Stocks
OncoCyte enters software collaboration with Echelon Diagnostics » 08:05
06/15/21
06/15
08:05
06/15/21
08:05
OCX

OncoCyte

$5.21 /

-0.245 (-4.50%)

Echelon Diagnostics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OCX OncoCyte
$5.21 /

-0.245 (-4.50%)

OCX OncoCyte
$5.21 /

-0.245 (-4.50%)

04/12/21 Lake Street
AACR data strengthens 'pan-cancer credentials' for OncoCyte, says Lake Street
04/12/21 Piper Sandler
OncoCyte remains a top pick small-cap pick at Piper Sandler
03/30/21 Piper Sandler
OncoCyte called 'top small-cap pick' at Piper Sandler
03/17/21
Fly Intel: Top five analyst initiations
OCX OncoCyte
$5.21 /

-0.245 (-4.50%)

  • 05
    Feb
OCX OncoCyte
$5.21 /

-0.245 (-4.50%)

Recommendations
Aethlon Medical price target raised to $11 from $6 at Maxim » 08:04
06/15/21
06/15
08:04
06/15/21
08:04
AEMD

Aethlon Medical

$5.82 /

-0.61 (-9.49%)

Maxim analyst Anthony…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AEMD Aethlon Medical
$5.82 /

-0.61 (-9.49%)

AEMD Aethlon Medical
$5.82 /

-0.61 (-9.49%)

06/01/21 H.C. Wainwright
Aethlon Medical initiated with a Buy at H.C. Wainwright
01/08/21
Fly Intel: Top five analyst initiations
01/08/21 Maxim
Aethlon Medical initiated with a Buy at Maxim
AEMD Aethlon Medical
$5.82 /

-0.61 (-9.49%)

Recommendations
New York City REIT price target raised to $13 from $10 at B. Riley » 08:04
06/15/21
06/15
08:04
06/15/21
08:04
NYC

New York City REIT

$13.75 /

+1.83 (+15.35%)

B. Riley analyst Bryan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NYC New York City REIT
$13.75 /

+1.83 (+15.35%)

NYC New York City REIT
$13.75 /

+1.83 (+15.35%)

03/18/21 B. Riley Securities
New York City REIT price target lowered to $10 from $11.50 at B. Riley
10/20/20 B. Riley Securities
New York City REIT initiated with a Neutral at B. Riley Securities
10/20/20 B. Riley Securities
New York City REIT initiated with a Neutral at B. Riley Securities
NYC New York City REIT
$13.75 /

+1.83 (+15.35%)

Recommendations
Global Net Lease price target raised to $24 from $23 at B. Riley » 08:04
06/15/21
06/15
08:04
06/15/21
08:04
GNL

Global Net Lease

$19.98 /

+0.18 (+0.91%)

B. Riley analyst Bryan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GNL Global Net Lease
$19.98 /

+0.18 (+0.91%)

GNL Global Net Lease
$19.98 /

+0.18 (+0.91%)

03/01/21 B. Riley Securities
Global Net Lease price target raised to $23 from $21 at B. Riley Securities
09/22/20 Ladenburg
Ladenburg stays Neutral on Global Net Lease due to growth headwinds
06/30/20 Berenberg
Global Net Lease initiated with a Buy at Berenberg

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.